000 02390nam a22005175i 4500
001 978-3-642-20195-0
003 DE-He213
005 20140220083800.0
007 cr nn 008mamaa
008 110831s2011 gw | s |||| 0|eng d
020 _a9783642201950
_9978-3-642-20195-0
024 7 _a10.1007/978-3-642-20195-0
_2doi
050 4 _aRM1-950
072 7 _aMMG
_2bicssc
072 7 _aMED071000
_2bisacsh
082 0 4 _a615
_223
100 1 _aSeyberth, Hannsjörg W.
_eeditor.
245 1 0 _aPediatric Clinical Pharmacology
_h[electronic resource] /
_cedited by Hannsjörg W. Seyberth, Anders Rane, Matthias Schwab.
250 _aFirst.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2011.
300 _aXII, 384 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aHandbook of Experimental Pharmacology,
_x0171-2004 ;
_v205
505 0 _aPreface -- Part 1: General Considerations and methodological aspects -- Part 2: Development of pediatric medicines -- Part 3: Specific pediatric pharmacology.
520 _aThe objective of this volume is to give an overview of the present state of the art of pediatric clinical pharmacology including developmental physiology, pediatric-specific pathology, special tools and methods for development of drugs for children (assessment of efficacy, toxicity, long-term safety etc.) as well as regulatory and ethical knowledge and skills. In the future, structural and educational changes have to lead back to a closer cooperation and interaction of pediatrics with (clinical) pharmacology and pharmacy.
650 0 _aMedicine.
650 0 _aMedical laboratories.
650 0 _aToxicology.
650 0 _aPediatrics.
650 1 4 _aBiomedicine.
650 2 4 _aPharmacology/Toxicology.
650 2 4 _aPediatrics.
650 2 4 _aLaboratory Medicine.
700 1 _aRane, Anders.
_eeditor.
700 1 _aSchwab, Matthias.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783642201943
830 0 _aHandbook of Experimental Pharmacology,
_x0171-2004 ;
_v205
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-642-20195-0
912 _aZDB-2-SBL
999 _c107734
_d107734